Triple GLP- 1/GIP/Glucagon Receptor Agonists- Retatrutide Retatrutide is being developed as a once-weekly subcutaneous injection of a triple GLP- 1, GIP, and glucagon receptor agonist to treat T2DM [109]
As we expand our horizons, Daehan Nupharm aims to transform into a leading global pharmaceutical and biotechnology company
Aqua (Water), Melaleuca Alternifolia (Tea Tree) Leaf Water, Propanediol, Glycerin, 1,2-Hexanediol, Hydrogenated Polydecene, Vinyl Dimethicone, C14-22 Alcohols, Niacinamide, Caprylic/Capric Triglyceride, Panthenol, Dicaprylyl Carbonate, Butylene Glycol, Ammonium Acryloyldimethyltaurate/Vp Copolymer, Caprylyl Methicone, Polymethylsilsesquioxane, C12-20 Alkyl Glucoside, Hydroxyacetophenone, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Polyquaternium-51, Ethylhexylglycerin, Tromethamine, Sodium Hyaluronate, Sodium Stearoyl Glutamate, Coptis Japonica Root Extract, Centella Asiatica Leaf Water, Beta-Glucan, Resveratrol, Hydrolyzed Hyaluronic Acid, Camellia Sinensis Leaf Water, Tocopherol, Madecassoside, Sodium Dna, Centella Asiatica Extract, Ceramide Np, Tannic Acid, Disodium Edta, Sodium Phytate
Ensuring that your body gets the fuel it needs to keep up with your rigorous fitness regime is not easy, given the time constraints and busy schedules
Research Use Does Not Mean Approved Human Use A research use only or R&D only label does not prove product identity, purity, sterility or legal suitability for personal administration
What sizes are available